Skip to content

Bicara Therapeutics Inc.

BCAX Nasdaq SEC CIK 2023658

Follow Bicara Therapeutics Weekly email: filings, results, news

News

5 stories filed under Bicara Therapeutics, grouped into ongoing threads

Call

Thread · 2 stories

Bicara Therapeutics Inc. Common Stock Q2 2026 Earnings Call Summary

Earnings 44 d ago

Bicara Therapeutics Q2 Earnings Call Highlights

Earnings 44 d ago 2 sources

More coverage

Can Bicara (BCAX) Commercialize Ficera? Breakthrough 3-Year Data Faces Execution Risk in C-Suite Overhaul

Markets 36 d ago

Bicara Therapeutics: My Optimism Is Building Despite Recent Market Headwinds

Markets 43 d ago

Bicara Therapeutics stock gains 3% on pivotal trial enrollment progress

Markets 44 d ago

Profile

Headquarters: BOSTON, MA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 5 stories clustered from the RSS aggregator